RSBNL_HUMAN - dbPTM
RSBNL_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID RSBNL_HUMAN
UniProt AC Q6PCB5
Protein Name Round spermatid basic protein 1-like protein
Gene Name RSBN1L
Organism Homo sapiens (Human).
Sequence Length 846
Subcellular Localization Nucleus.
Protein Description
Protein Sequence MAEPPSPVHCVAAAAPTATVSEKEPFGKLQLSSRDPPGSLSAKKVRTEEKKAPRRVNGEGGSGGNSRQLQPPAAPSPQSYGSPASWSFAPLSAAPSPSSSRSSFSFSAGTAVPSSASASLSQPVPRKLLVPPTLLHAQPHHLLLPAAAAAASANAKSRRPKEKREKERRRHGLGGAREAGGASREENGEVKPLPRDKIKDKIKERDKEKEREKKKHKVMNEIKKENGEVKILLKSGKEKPKTNIEDLQIKKVKKKKKKKHKENEKRKRPKMYSKSIQTICSGLLTDVEDQAAKGILNDNIKDYVGKNLDTKNYDSKIPENSEFPFVSLKEPRVQNNLKRLDTLEFKQLIHIEHQPNGGASVIHAYSNELSHLSPMEMERFAEEFVGLVFSENENSAAFYVMGIVHGAATYLPDFLDYFSFNFPNSPVKMEILGKKDIETTTMSNFHAQVKRTYSHGTYRAGPMRQISLVGAVDEEVGDYFPEFLDMLEESPFLKCTLPWGTLSSLKLQSRKDSDDGPIMWVRPGEQMIPVADMPKSPFKRKRTTNEIKNLQYLPRTSEPREMLFEDRTRAHADHIGQGFERQTTAAVGVLKAVHCGEWPDQPRITKDVICFHAEDFLEVVQRMQLDLHEPPLSQCVQWVDDAKLNQLRREGIRYARIQLYDNDIYFIPRNVVHQFKTVSAVCSLAWHIRLKLYHSEEDTSQNTATHETGTSSDSTSSVLGPHTDNMICAVSKASLDSVFSDKLHSKYELQQIKHEPIASVRIKEEPVNVNIPEKTTALNNMDGKNVKAKLDHVQFAEFKIDMDSKFENSNKDLKEELCPGNLSLVDTRQHSSAHSNQDKKDDDILC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAEPPSPVH
------CCCCCCCCC
37.6919413330
6Phosphorylation--MAEPPSPVHCVAA
--CCCCCCCCCEEEE
50.7129255136
17PhosphorylationCVAAAAPTATVSEKE
EEEECCCCCEECCCC
30.1820068231
19PhosphorylationAAAAPTATVSEKEPF
EECCCCCEECCCCCC
27.3520068231
21PhosphorylationAAPTATVSEKEPFGK
CCCCCEECCCCCCCC
38.3020068231
28AcetylationSEKEPFGKLQLSSRD
CCCCCCCCCCCCCCC
33.1819608861
32PhosphorylationPFGKLQLSSRDPPGS
CCCCCCCCCCCCCCC
15.4625159151
33PhosphorylationFGKLQLSSRDPPGSL
CCCCCCCCCCCCCCC
49.66-
39PhosphorylationSSRDPPGSLSAKKVR
CCCCCCCCCCCCCCC
25.5621815630
41PhosphorylationRDPPGSLSAKKVRTE
CCCCCCCCCCCCCCC
39.4821815630
43AcetylationPPGSLSAKKVRTEEK
CCCCCCCCCCCCCCC
48.7225953088
44UbiquitinationPGSLSAKKVRTEEKK
CCCCCCCCCCCCCCC
36.3424816145
44AcetylationPGSLSAKKVRTEEKK
CCCCCCCCCCCCCCC
36.3411924383
51UbiquitinationKVRTEEKKAPRRVNG
CCCCCCCCCCCCCCC
67.8924816145
62PhosphorylationRVNGEGGSGGNSRQL
CCCCCCCCCCCCCCC
55.1527174698
76PhosphorylationLQPPAAPSPQSYGSP
CCCCCCCCCCCCCCC
30.7422199227
79PhosphorylationPAAPSPQSYGSPASW
CCCCCCCCCCCCCCC
34.5422199227
80PhosphorylationAAPSPQSYGSPASWS
CCCCCCCCCCCCCCC
19.1722199227
82PhosphorylationPSPQSYGSPASWSFA
CCCCCCCCCCCCCCC
14.7322199227
85PhosphorylationQSYGSPASWSFAPLS
CCCCCCCCCCCCCCC
27.0022199227
87PhosphorylationYGSPASWSFAPLSAA
CCCCCCCCCCCCCCC
14.7222199227
92PhosphorylationSWSFAPLSAAPSPSS
CCCCCCCCCCCCCCC
22.7122199227
92O-linked_GlycosylationSWSFAPLSAAPSPSS
CCCCCCCCCCCCCCC
22.7123301498
96PhosphorylationAPLSAAPSPSSSRSS
CCCCCCCCCCCCCCC
32.4622199227
96O-linked_GlycosylationAPLSAAPSPSSSRSS
CCCCCCCCCCCCCCC
32.4623301498
98O-linked_GlycosylationLSAAPSPSSSRSSFS
CCCCCCCCCCCCCEE
45.3323301498
98PhosphorylationLSAAPSPSSSRSSFS
CCCCCCCCCCCCCEE
45.3322199227
99PhosphorylationSAAPSPSSSRSSFSF
CCCCCCCCCCCCEEE
32.9119690332
99O-linked_GlycosylationSAAPSPSSSRSSFSF
CCCCCCCCCCCCEEE
32.9123301498
100O-linked_GlycosylationAAPSPSSSRSSFSFS
CCCCCCCCCCCEEEE
40.2823301498
100PhosphorylationAAPSPSSSRSSFSFS
CCCCCCCCCCCEEEE
40.2822199227
102PhosphorylationPSPSSSRSSFSFSAG
CCCCCCCCCEEEECC
37.3725159151
102O-linked_GlycosylationPSPSSSRSSFSFSAG
CCCCCCCCCEEEECC
37.3723301498
103PhosphorylationSPSSSRSSFSFSAGT
CCCCCCCCEEEECCC
24.6525159151
103O-linked_GlycosylationSPSSSRSSFSFSAGT
CCCCCCCCEEEECCC
24.6523301498
105PhosphorylationSSSRSSFSFSAGTAV
CCCCCCEEEECCCCC
21.9026434776
107PhosphorylationSRSSFSFSAGTAVPS
CCCCEEEECCCCCCC
25.2927080861
110PhosphorylationSFSFSAGTAVPSSAS
CEEEECCCCCCCCCC
24.9727080861
115O-linked_GlycosylationAGTAVPSSASASLSQ
CCCCCCCCCCCCCCC
21.8523301498
183PhosphorylationAREAGGASREENGEV
HHHCCCCCHHCCCCC
43.4226714015
191AcetylationREENGEVKPLPRDKI
HHCCCCCCCCCHHHH
36.2123749302
191UbiquitinationREENGEVKPLPRDKI
HHCCCCCCCCCHHHH
36.2124816145
201UbiquitinationPRDKIKDKIKERDKE
CHHHHHHHHHHHHHH
51.1524816145
223SumoylationHKVMNEIKKENGEVK
HHHHHHHHHHCCCEE
48.1028112733
235PhosphorylationEVKILLKSGKEKPKT
CEEEEEECCCCCCCC
55.8824505115
250UbiquitinationNIEDLQIKKVKKKKK
CHHHHHHHHHHHHHH
38.2529967540
250AcetylationNIEDLQIKKVKKKKK
CHHHHHHHHHHHHHH
38.2525953088
251UbiquitinationIEDLQIKKVKKKKKK
HHHHHHHHHHHHHHH
62.00-
273PhosphorylationRKRPKMYSKSIQTIC
HHCHHHHHHHHHHHH
19.2124719451
278 (in isoform 2)Ubiquitination-23.4521890473
278PhosphorylationMYSKSIQTICSGLLT
HHHHHHHHHHHCCCC
23.4527690223
278UbiquitinationMYSKSIQTICSGLLT
HHHHHHHHHHHCCCC
23.4521890473
281PhosphorylationKSIQTICSGLLTDVE
HHHHHHHHCCCCCHH
28.7326552605
285PhosphorylationTICSGLLTDVEDQAA
HHHHCCCCCHHHHHH
42.9427422710
301UbiquitinationGILNDNIKDYVGKNL
HHCCHHHHHHCCCCC
49.6229967540
303PhosphorylationLNDNIKDYVGKNLDT
CCHHHHHHCCCCCCC
13.1930576142
306AcetylationNIKDYVGKNLDTKNY
HHHHHCCCCCCCCCC
44.2725953088
306UbiquitinationNIKDYVGKNLDTKNY
HHHHHCCCCCCCCCC
44.2729967540
313PhosphorylationKNLDTKNYDSKIPEN
CCCCCCCCCCCCCCC
24.1323186163
315PhosphorylationLDTKNYDSKIPENSE
CCCCCCCCCCCCCCC
23.3328112733
321PhosphorylationDSKIPENSEFPFVSL
CCCCCCCCCCCCCCC
38.6623186163
327PhosphorylationNSEFPFVSLKEPRVQ
CCCCCCCCCCCHHHH
33.8228555341
329AcetylationEFPFVSLKEPRVQNN
CCCCCCCCCHHHHCC
59.1623236377
329UbiquitinationEFPFVSLKEPRVQNN
CCCCCCCCCHHHHCC
59.1629967540
338AcetylationPRVQNNLKRLDTLEF
HHHHCCHHCCCEEEE
53.7025953088
342PhosphorylationNNLKRLDTLEFKQLI
CCHHCCCEEEEHHHE
32.5524247654
440PhosphorylationGKKDIETTTMSNFHA
CCCCCEECCCCCCHH
14.0120068231
450AcetylationSNFHAQVKRTYSHGT
CCCHHEEEECCCCCC
27.267710369
457PhosphorylationKRTYSHGTYRAGPMR
EECCCCCCEECCCCE
12.38-
458PhosphorylationRTYSHGTYRAGPMRQ
ECCCCCCEECCCCEE
11.76-
490PhosphorylationFLDMLEESPFLKCTL
HHHHHHHCCCCEEEC
16.1526074081
496PhosphorylationESPFLKCTLPWGTLS
HCCCCEEECCCCCHH
33.9826074081
501PhosphorylationKCTLPWGTLSSLKLQ
EEECCCCCHHHEEEC
21.4326074081
503PhosphorylationTLPWGTLSSLKLQSR
ECCCCCHHHEEECCC
33.2026074081
504PhosphorylationLPWGTLSSLKLQSRK
CCCCCHHHEEECCCC
32.4126699800
506UbiquitinationWGTLSSLKLQSRKDS
CCCHHHEEECCCCCC
46.56-
509PhosphorylationLSSLKLQSRKDSDDG
HHHEEECCCCCCCCC
52.3026074081
536PhosphorylationPVADMPKSPFKRKRT
ECCCCCCCCCCCCCC
29.6925159151
548UbiquitinationKRTTNEIKNLQYLPR
CCCCHHHCCCCCCCC
45.4823000965
548 (in isoform 1)Ubiquitination-45.4821890473
548SumoylationKRTTNEIKNLQYLPR
CCCCHHHCCCCCCCC
45.4828112733
552PhosphorylationNEIKNLQYLPRTSEP
HHHCCCCCCCCCCCC
23.1125003641
557PhosphorylationLQYLPRTSEPREMLF
CCCCCCCCCCHHHHH
47.0528555341
734PhosphorylationICAVSKASLDSVFSD
EEEEEHHHHHHHHHH
36.1223663014
742AcetylationLDSVFSDKLHSKYEL
HHHHHHHHHHCCCCH
47.0725953088
746AcetylationFSDKLHSKYELQQIK
HHHHHHCCCCHHHCC
31.8125953088
746UbiquitinationFSDKLHSKYELQQIK
HHHHHHCCCCHHHCC
31.8129967540
753SumoylationKYELQQIKHEPIASV
CCCHHHCCCCCCEEE
37.2628112733
753SumoylationKYELQQIKHEPIASV
CCCHHHCCCCCCEEE
37.26-
763SumoylationPIASVRIKEEPVNVN
CCEEEEEEECCCCCC
45.52-
763SumoylationPIASVRIKEEPVNVN
CCEEEEEEECCCCCC
45.5228112733
774AcetylationVNVNIPEKTTALNNM
CCCCCCCCCCCCCCC
45.9125953088
784AcetylationALNNMDGKNVKAKLD
CCCCCCCCCCEEECC
55.0625953088
789AcetylationDGKNVKAKLDHVQFA
CCCCCEEECCEEEEE
49.0525953088
814SumoylationENSNKDLKEELCPGN
CCCCHHHHHHHCCCC
60.31-
814SumoylationENSNKDLKEELCPGN
CCCCHHHHHHHCCCC
60.3128112733
823PhosphorylationELCPGNLSLVDTRQH
HHCCCCCEEEECCCC
30.2821815630
827PhosphorylationGNLSLVDTRQHSSAH
CCCEEEECCCCCCCC
25.4220068231

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of RSBNL_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of RSBNL_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of RSBNL_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
RSBN1_HUMANRSBN1physical
28514442
PININ_HUMANPNNphysical
28514442
CLK2_HUMANCLK2physical
28514442
SRRM2_HUMANSRRM2physical
28514442
NKAP_HUMANNKAPphysical
28514442
RNPS1_HUMANRNPS1physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of RSBNL_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-28, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-6, AND MASS SPECTROMETRY.

TOP